¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.

Français
Author : 
Salaun, PY ; Campion, L ; Ansquer, C ; Frampas, E ; Mathieu, C ; Robin, P & al
Newspaper edition : 
Eur. J. Nucl. Med. Mol. Imaging - Année 2014 - Volume 41 - Page 1501-10 - PMID 24806110